VERA
Vera Therapeutics Inc
NASDAQ: VERA · HEALTHCARE · BIOTECHNOLOGY
$35.84
-3.42% today
Updated 2026-04-29
Market cap
$2.57B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-4.66
Dividend yield
—
52W range
$19 – $56
Volume
1.2M
Vera Therapeutics Inc (VERA) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-50.70%
ROA
-28.40%
Debt/equity
0.19x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $0.00 | $-11.85M | — | — | — |
| 2020 | $0.00 | $-53.41M | — | — | — |
| 2021 | $0.00 | $-32.61M | — | — | — |
| 2022 | $0.00 | $-89.06M | — | — | — |
| 2023 | $1.86M | $-95.99M | 100.00% | -5,478.63% | -5,155.21% |
| 2024 | $0.00 | $-152.15M | — | — | — |
| 2025 | $0.00 | $-299.62M | — | — | — |